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RNA maturationFormation of immature genomic RNA (gRNA) dimers is exquisitely nucleocapsid (NC)-dependent in
protease-inactive (PR-in) HIV-1. This establishes that Pr55gag/Pr160gag-pol has NC-dependent chaperone
activity within intact HIV-1. Mutations in the proximal zinc ﬁnger and the linker of the NC sequence of
Pr55gag/Pr160gag-pol abolish gRNA dimerization in PR-in HIV-1. In wild type, where the NC of Pr55gag is
processed into progressively smaller proteins termed NCp15 (NCp7-p1-p6), NCp9 (NCp7-p1) and NCp7,
formation of immature dimers is much swifter than in PR-in HIV-1. NCp7 and NCp15 direct this rapid
accumulation. NCp9 is sluggish in this process, but it stimulates the transition from immature to mature
gRNA dimer as well as NCp7 and much better than NCp15. The amino-terminus, proximal zinc ﬁnger, linker,
and distal zinc ﬁnger of NCp7 contribute to this maturation event in intact HIV-1. The DIS is a dimerization
initiation site for all immature gRNA dimers, irrespective of their mechanism of formation.dical Research, 3755 Cote Ste
514 340 7502.
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All retroviruses contain a dimeric genomic RNA (gRNA). The dimeric
nature of HIV-1 RNA appears essential for viral infectivity because,
among other effects, it facilitates gRNA strand exchange during reverse
transcription (Chin et al., 2005, 2007, 2008). Two kinds of dimers have
been extracted from HIV-1: immature dimers, typically seen in
protease-inactive (PR-in) HIV-1; mature dimers, seen exclusively in
wild type (WT) (Fu et al., 1994; Song et al., 2007). In PR-in HIV-1, the
viral protease is inactivated by mutational or chemical means; as a
result the Gag (Pr55gag) and Gagpol (Pr160gag-pol) precursor
polyproteins remain uncleaved. [There are roughly 2400 Pr55gag and
120 Pr160gag-pol in immature HIV-1 (Benjamin et al., 2005; Carlson et
al., 2008).] Immature and mature gRNA dimers differ in conformation,
but not in sequence.Formation of immature gRNA dimers (igRNAds) is often thought to
be a spontaneous process in PR-in HIV-1 (Song et al., 2007). However,
Kafaie et al. (2008) found a greater percentage of gRNA dimers in
PR-in HIV-1 than in two WT HIV-1 mutated in NC. They hypothesized
that PR-in gRNA dimerization ismediated by unprocessed viral proteins
such as Pr55gag. [Pr55gag can stimulate dimerization of partial HIV-1
RNA transcripts in vitro (Feng et al., 1999).] To test this hypothesis, we
studied the effect of NCmutations on the level of gRNA dimers in PR-in
HIV-1.We found that gRNA dimerization could be abolished by some of
these mutations; we identiﬁed NC residues and domains that mediate
this protein dependent formation of igRNAds, and others that do not.
Formation of igRNAds is much swifter in WT than in PR-in HIV-1
(Song et al., 2007), but the extent of Pr55gag/Pr160gag-pol processing
required for this process is unknown. As Pr55gag is proteolytically
processed, its nucleocapsid (NC) sequence becomes part of progres-
sively smaller proteins termed NCp15 (NCp7-p1-p6), NCp9 (NCp7-p1)
andNCp7, thenumbers approximatingmolecularweights in kilodaltons
(Erickson-Viitanen et al., 1989; Pettit et al., 1994, 2002; Wondrak et al.,
1993). These four proteins account for 95% of NCs. We studied the
kinetics of gRNA dimerization in HIV-1 that cannot further process
NCp15, and inHIV-1 that cannot further process NCp9, respectively.We
show that NCp9 produces igRNAdsmuchmore slowly than NCp15. This
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immature dimers in WT.
The transformation of igRNAds into mature gRNA dimers requires
processing of Pr55gag/Pr160gag-pol (Fu et al., 1994), but the proteins
responsible for this conformational change are unknown. Here, we
show that NCp15 is inactive in this processwhile NCp9 appears as active
as NCp7. The NC residues or segments responsible for the transforma-
tion of igRNAds into mature gRNA dimers are also unknown because
Kafaie et al. (2008) did not report the effect of NC mutations on gRNA
dimer maturation. [Dimer maturation is characterized by a change in
electrophoretic migration: mature gRNA dimers migrate faster than
igRNAds (Fu et al., 1994; Songet al., 2007).] All autoradiogramsobtained
by Kafaie et al. (2008, 2009) during the course of their studies were
reanalyzed, with emphasis on recording the precise electrophoretic
migration of the dimer bands. We found that most NC mutations that
reduced dimerization yield also reduced dimer migration. This suggests
that they impaired both formation of igRNAds and transformation
of immature dimers into mature dimers.
The dimerization initiation site (DIS) is a six nucleotide palin-
drome located in the apical loop of SL1 (Shen et al., 2000, 2001); SL1 is
a 35 nucleotide-long stem-loop located in the 5' untranslated region
of gRNA. The DIS is recognized as a signiﬁcant dimerization initiation
site in WT HIV-1 (Song et al., 2007). Here we show that formation of
immature gRNA dimers is DIS dependent in PR-in HIV-1 and in p15
HIV-1 (HIV-1 that cannot process Pr55gag beyond the NCp15 level).
This extends previous results indicating that the DIS is important for a
high level of gRNA dimers in newly released WT HIV-1 (Song et al.,
2007), and suggests that the DIS plays similar roles in formation of
immature dimers in PR-in, p15, and WT HIV-1, as if these immature
dimers were characterized by identical intermolecular interactions.Fig. 1. (A) Proteolytic processing of Pr55gag in HIV-1HXB2 prepared from cells incubated in th
were analyzed by SDS-polyacrylamide gel electrophoresis, followed by visualization by W
Pr55gag runs at the p55 position. After partial proteolysis of Pr55gag, the capsid protein is p
and electrophoretic migration of viral RNA isolated from protease-inactive HIV-1 (PR−), H
PR−HIV-1 was prepared bymutating the active site of the viral protease (Song et al., 2007)
gRNA samples were 57±5.8% dimeric (n=6). D: dimer, M: monomer.Results
(A) Immature gRNA dimers form in a protein dependent manner in
PR-in HIV-1
To study whether formation of gRNA dimers is spontaneous or
protein-dependent in protease-inactive (PR-in) HIV-1, we prepared
PR-in HIV-1 mutated in NC. HeLa cells were transfected in parallel
with equal amounts of pSVC21.BH10 or proviral vectors mutated in
the NC sequence. Proviral vector pSVC21.BH10 encodes an infectious
HIV-1HXB2 molecular clone derived from the IIIB strain of HIV-1
(Laughrea et al., 1997). Shortly after transfection, 0.6 μM of the
protease inhibitor saquinavir was added. This inhibits viral protease
activity to a N97% level, as shown by Western blot analysis of
proteolytic processing of Pr55gag (Fig. 1A). After 48 h, viruses were
isolated from the culture supernatant, and their gRNA was extracted,
electrophoresed on a non-denaturing agarose gel and visualized by
Northern blotting with a 35S-labeled HIV-1 riboprobe, followed by
autoradiography. WT HIV-1 grown in the presence of 0.6 μM
saquinavir are termed “controls” or “PR-in”; “WT” is usually reserved
for WT HIV-1 grown without saquinavir. Fig. 1B conﬁrms that PR-in
HIV-1 (lane 3) contain only immature gRNA dimers and monomers,
and in quantities similar to what is seen in PR— HIV-1, HIV-1 that
are made protease-inactive by mutating the viral protease active site
aspartic acid at position 25 (lane 1). In contrast, and as expected, WT
HIV-1 contains only mature (fast migrating) gRNA dimers (lane 2).
NC possesses two zinc-containingmotifs (often called zinc ﬁngers)
separated by a highly basic linker sequence (Berg and Shi, 1996; Bess
et al., 1992; Green and Berg, 1989; Wain-Hobson et al., 1985). Among
the 55 amino acid residues of NCp7, 15 are highly basic and only foure presence of 0.1 μM to 1 μM saquinavir (SQV). Proteins extracted from puriﬁed viruses
estern blotting using polyclonal antibodies directed against the capsid protein CAp24.
art of a matrix-capsid oligoprotein running at the p41 position. (B) Dimerization level
IV-1HXB2, and HIV-1HXB2 produced in the presence of 0.6 μM saquinavir (HXB2+SQV).
. Saquinavir-treated HIV-1HXB2 gRNA samples were 60±3% dimeric (n=13) and PR−
Fig. 2. Dimerization level of viral RNA isolated from protease-inactive HIV-1HXB2
mutated in the linker segment (A), or in two separate segments (B), of the nucleocapsid
protein. For all lanes, transfected cells were incubated with 0.6 μM saquinavir to
produce protease-inactive HIV-1. Autoradiographic exposure times varied from 30 min
to 18 h. Each lane contained RNAs isolated from 24 ml of ﬁltered supernatant.
Table 2
Effect of NCmutations on gRNA dimerization in protease-inactive HIV-1 (+SQV) and in
wild-type HIV-1 (−SQV).
Region Construct
Namea
Protease-inactiveb
(+SQV)
Protease-activec
(−SQV)
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and FL (Fig. 2; Table 1). Mutations S3E and FL essentially blocked
formation of immature gRNA dimers (igRNAds) in PR-in HIV-1
(Fig. 2A lane 2 and B lane 2). This suggests that formation of igRNAds
is not a protein-free process in PR-in HIV-1. We proceeded to map the
NC residues important for gRNA dimerization in PR-in HIV-1.
Effect of mutations within the linker of the nucleocapsid sequence of
PR-in HIV-1
No gRNA dimer peak was generally visible in the S3E mutant
(Fig. 2A, lane 2). Assuming that all material in the faint low mobility
shoulder corresponds to dimeric RNA, S3E gRNA dimerization was
~30% of control level (Table 2); b30% if some of this trace intensity is
considered background. Deleting the linker (Δlinker) or making it
hydrophobic (FVI) reduced the proportion of gRNA dimers to ~55%
and ~45% of controls, respectively (Fig. 2A, lanes 3 and 4; Table 2).
Since S3E had a larger impact than Δlinker, it is likely that S3E has
pleiotropic effects such as impairing adjacent NC segments, or the
linker and adjacent segments.
Neutralizing the linker did not perturb gRNA dimerization, as shown
by mutation S3, which replaces ArgLysLys34 by SerSerSer (Fig. 2A, lane
5; Table 2). This suggests that gRNA dimerization in PR-in HIV-1 does
not depend on the electric charge of the linker. Deleting the linker,
making it hydrophobic, or negatively charged (S3E), could have entirely
allosteric effects on gRNA dimerization in PR-in HIV-1. In Δlinker, the
two zincﬁngersmaybe so close that this hinders one of them; in FVI and
S3E, the radical change in hydrophobicity and/or charge could seriously
impair zinc ﬁnger function. If true, at least one zinc ﬁnger should prove
important for gRNA dimerization in PR-in HIV-1.
Effect of mutations within the amino-terminal segment or the N-terminal
zinc ﬁnger
Mutation R7 reduced the charge of the N-terminal segment by
60%; mutation N+ increased it by 40% (Table 1). None of them
reduced gRNA dimerization in PR-in HIV-1 (Fig. 3A; Table 2). The basic
residues of the N-terminus of NC do not appear to stimulate PR-in
gRNA dimerization, much like the basic residues of the linker (see
mutation S3).
Deleting zinc ﬁnger 1 (ΔF1; Table 1) essentially abolished gRNA
dimerization in PR-in HIV-1: no dimer band was ever visible in any ofTable 1
Mutations introduced into the NC protein of HIV-1HXB2. The wild-type sequence is
indicated at the top. The sequence is divided into segments and the residue number
corresponding to the ﬁrst residue of each segment is shown. One letter abbreviations
are used for each amino acid residue. Hyphens indicate amino acid residues that are the
same as wild type. Deletions are shown by blank spaces in the mutant sequences.the tested samples. Counting as dimers the background material
located at the dimer position, we ﬁnd that the proportion of gRNA
dimers in the ΔF1 mutant was ~12%, i.e. ~20% of control PR-in virions
(Fig. 3B, lane 2; Table 2). Mutations H23A and 2GAF1 reduced the
proportion of gRNA dimers to 32% and 37% respectively, i.e.
approximately 53% and 62% of controls (Fig. 3B, lanes 4 and 5;HXB2 100 100
N-terminus N+ 103±2.5 102±3
R7 98±3.5 77±2
Zinc ﬁnger 1 ΔF1 20±7 72.5±3
H23A 53±3 69±4
2GAF1 62±7.5 73±3
C28S 82±5 81±3.5
Linker S3E 32±7 45±2
FVI 45±10 74±2
ΔLinker 55±8.5 75±2
S3 93±2 94±3.5
Zinc Finger 2 K38N 105±3 101±4
2KAF2 103±2.5 94±2
ΔF2 95±3 76±1.5
NC 1-1 85±5 84±1
2KEF2 57±3.5 75±2
H44A 48±4.5 70±2
2GAF2 38±2 65±2
Joint mutations FL 12±6 46±3.5
HC 35±6 61±1.5
The percentage of gRNA dimers was arbitrarily set at 100 for HIV-1HXB2, and the values
for mutants were expressed as % of wild-type level. Dimerization numbers were
obtained by densitometric analysis. Margins of error designate standard error of results
from 3 to 13 independent transfections.
a Mutations are deﬁned in Table 1.
b 0.6 μM saquinavir (SQV) was used to inhibit the HIV-1 protease. RNA from
protease-inactive HIV-1HXB2 was 60% dimeric (Fig. 1).
c From Kafaie et al. (2008). RNA from protease-active HIV-1HXB2 was 77% dimeric.
Fig. 3. Dimerization level of viral RNA isolated from protease-inactive HIV-1HXB2
mutated in the N-terminus segment (A), or in the N-terminal zinc ﬁnger (B) of the
nucleocapsid protein. Experimental conditions as in Fig. 2. Exposure times varied from
30 min to 18 h.
Fig. 4. Dimerization level of viral RNA isolated from protease-inactive HIV-1HXB2
mutated in the C-terminal zinc ﬁnger of the nucleocapsid protein. Experimental
conditions were as in Fig. 2. Exposure times varied from 40 min to 7 h.
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to ~80% of controls (Fig. 3B, lane 3; Table 2). [In NCp7, C28S reduces
Zn2+ binding afﬁnity N40-fold (Mely et al., 1996); this reduced
afﬁnity may be similar to that of various host zinc binding proteins
(Bombarda et al., 2002).]
The diffuse character of some RNA bands, which was also seen in
Kafaie et al. (2008), may reﬂect conformational diversity among
gRNAs from NC-mutated HIV-1. It is not due to poor gel resolution.
The RNA bands seen here are not more diffuse, and sometimes
sharper, than what was seen in earlier studies (Buxton et al., 2005;
Clever and Parslow, 1997; Kafaie et al., 2008; Laughrea et al., 1997;
Sakuragi and Panganiban, 1997; Shen et al., 2000).Effect of joint mutations involving two nucleocapsid segments of PR-in
HIV-1
Mutation FL (H23A + FVI; Table 1) reduced the proportion of
gRNA dimers to ~7%, i.e. ~12% of control level (Fig. 2B, lane 2; Table 2),
and no dimer band was ever visible in any of the tested samples. Thus
mutations H23A and FVI had synergistic effects. Little evidence of a
dimer peak was found in gRNAs from mutant HC (C28H + H44C)
(Fig. 2B, lane 3; Table 2). Their dimerization level was no more than
~21%, i.e. ~35% of control level (Table 2).Effect of mutations in the C-terminal zinc ﬁnger of PR-in HIV-1
Deleting zinc ﬁnger 2 (ΔF2) had no effect, suggesting that the
distal zinc ﬁnger plays no role in PR-in gRNA annealing. In accordance,
mutations K38N, 2KAF2 and NC1-1 had no or little inhibitory effects
on PR-in gRNA dimerization (Fig. 4, lanes 3–5, Table 2). On the other
hand, mutations H44A, 2GAF2, and 2KEF2 reduced gRNA dimerization
to approximately 48, 38 and 57% of control level, respectively (Fig. 4,
lanes 6–8; Table 2). These 3 mutations may directly or indirectly
interfere with the proximal zinc ﬁnger (see Discussion).(B) Formation of immature gRNA dimers is swift in the presence of NCp7
or NCp15, but slow in the presence of NCp9
We have seen that slow formation of igRNAds is mediated by the
NC of Pr55gag/Pr160gag-pol (Table 2), while fast formation of
igRNAds (Song et al., 2007), as well as their conversion into mature
dimers (Fu et al., 1994; Song et al., 2007), requires proteolytic
processing of Pr55gag/Pr160gag-pol. Four gaps remain in our
understanding. (1) Is fast formation of igRNAds mediated by NC? In
the afﬁrmative, which NC is most implicated: NCp15, NCp9 or NCp7?
(2) Is dimer maturation mediated by processed NC, or by mere steric
relief such as disappearance of Pr55gag? (3) Are immature dimers
formed inside the cell in WT, i.e. is gRNA packaged as an immature
dimer in WT? (4) If the answer to question 2 is afﬁrmative, which
residues or segments of NC are most implicated in dimer maturation?
To answer the ﬁrst question, we evaluated the effects of NCp15
(i.e. blocking production of NCp9 and NCp7), NCp9 (i.e. blocking
production of NCp7) and NCp7 on immature dimer formation. To this
end, we prepared p9 HIV-1, in which Asn55 of NCp7 is replaced by
serine, and p15 HIV-1, in which Asn55 of NCp7 and Phe16 of p1 are
replaced by serines. The level of Pr55gag processing was assessed in
puriﬁed HIV-1 by immunoblotting using antibodies against NCp7
(Fig. 5). Mutation p9 blocked proteolytic maturation of NCp9 into
NCp7 and p1, both in isolated viruses (Fig. 5, lanes 2 and 4; Kafaie et
al., 2009; Pettit et al., 2002) and in vitro, when recombinant HIV-1
protease reacted with the Gag polyprotein (Pettit et al., 2002).
Mutation p15 dramatically reduced proteolytic maturation of NCp15
without affecting cleavage at its N-terminus (Fig. 5, lane 3). To assess
NCp7, we studied gRNA dimerization in 5-min-old WT, relative to p9
HIV-1 (no NCp7 produced); for NCp15, we studied 5-min-old p15
HIV-1 (no NCp9 and no NCp7 produced), relative to p9 HIV-1. If
NCp15 or NCp9 sufﬁce for fast formation of igRNAds, the level of
immature dimers should be the same in 5-min-old p9, p15 and WT
Fig. 5. Immunoblot of p9 and p15 HIV-1 preparations. Proteins were extracted from
puriﬁed WT, p9, and p15 HIV-1, and analyzed by SDS gel electrophoresis. Resolved
proteins were visualized using NCp7-reactive antibodies. Identities of bands are
indicated at the margins of the blot.
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only grown-up HIV-1 (Kafaie et al., 2009).
In 5-min-old p9, p15 andWT HIV-1, gRNAs were 24%, 62% and 73%
dimeric, respectively, and these dimers had the same low electro-
phoretic mobility (Fig. 6A, lanes 1–3; Fig. 6B and C). The p9 result is
the ﬁrst direct evidence that mutations in NC impair formation of
immature dimers in WT. Four ideas may come to mind to explain the
striking contrast between the p9 and the p15 results. (1) Asn55-NSer
may dramatically impair dimerization independently of its role in
proteolytic processing. However, Asn55-NSer did not impair dimer-
ization in p15 HIV-1; it is a theoretically mild mutation, and previous
NC mutations involving Asn, such as Asn17-NLys and Lys38-NAsn, did
not affect gRNA dimerization (Kafaie et al., 2008). (2) NCp9 may
disrupt the gRNA dimers produced by NCp15; these dimers would
later reform under the direction of NCp7. However, gRNA dimeriza-
tion increases with time in p9 HIV-1 (Fig. 6B), indicating that NCp9
does not disrupt gRNA dimers but stimulate their formation. (3) Virus
release may be delayed in p15 HIV-1, giving gRNAs more time to
become immature dimers intracellularly, i.e. giving NCp15 time to
produce a large proportion of igRNAds in newly released p15 HIV-1.
However, after transfection using WT, p9 and p15 proviral vectors,
CAp24 start to appear in the supernatant at identical times (±1 h),
and their concentrations increase at identical rates (not shown); it
was recently shown that assembly and release of HIV-1 produced by
transfected HeLa cells takes the same time no matter whether virions
areWT or protease-inactive (Ivanchenko et al., 2009). (4) NCp9 forms
igRNAds less effectively than NCp15 (2.5 fold less effectively if all
gRNA dimers seen in 5 min p9 HIV-1 are formed by NCp9, 10 fold less
effectively if 75% of them are formed by NCp15, etc.). Since NCp15 is
swiftly processed in vivo (Kaplan et al., 1994; Veronese et al., 1987)
and in vitro (Pettit et al., 2002), it is easy to conceive that it did not
have time to produce more than a 24% proportion of igRNAds in p9
HIV-1.
The ﬁrst explanation seems highly unlikely; the second and third
ones appear refuted. The fourth explanation is the simplest. It has
three implications. (1) Formation of igRNAds is predominantly drivenby NCp7 inWT (assuming NCp15 is as transient inWT as in p9 HIV-1):
see the increase from 24% to 73% dimers in 5-min-old p9 andWT HIV-
1 (Fig. 6A and B). (2) NCp15 is more potent than NCp9 in formation of
igRNAds, and almost as potent as NCp7. Note that the proportion of
igRNAds in budding p9 HIV-1 is necessarily ≤24% (it cannot be larger
than after virus release, unless NCp9 disrupts gRNA dimers, whichwas
refuted in explanation #2); it follows that if N24% of WT gRNA is
packaged as immature dimers, this dimerization must be driven by
intracellular NCp7.
Thus, we can answer question one: NC mediates fast formation of
igRNAds, and NCp7 is the most implicated NC in this process. Without
NCp7, the amount of igRNAds in newly released HIV-1 is reduced by a
factor three (Fig. 6B). NCp9 is at least three times slower than NCp7
and 2.5 times slower than NCp15 in producing igRNAds; if it were not
so transient, NCp15 would be strongly implicated in formation of
igRNAds in WT. The small proportion of immature dimers in 5 min p9
HIV-1, the large proportion in 5 min p15 HIV-1, and the slow rate of
accumulation of igRNAds in p9 HIV-1, together raise the possibility
that most dimeric gRNAs found in 5 min p9 HIV-1 are produced by
NCp15.
(C) NCp15 cannot transform immature dimers into mature dimers;
NCp7 is not needed, because NCp9 is sufﬁcient
Fig. 6A also shows that gRNA dimers from 48 h p15 and PR-in HIV-1
have low (immature) electrophoreticmobilities (lanes 4–6). In contrast,
gRNA dimers from 48 h p9 and WT HIV-1 migrate faster (lanes 7–8).
This is conﬁrmed by Fig. 6C. Thus p15 HIV-1 is unable to mature
igRNAds, in contrastwithp9HIV-1. This answers the secondquestion (is
dimermaturationmediated by processedNC, or by the disappearance of
Pr55gag?): disappearance of Pr55gag does not sufﬁce to transform
igRNAds into mature dimers; NC needs to be processed beyond the
NCp15 level. Kinetic experiments (below) will show that NCp9 appears
at least as potent as NCp7 in transforming igRNAds into mature dimers.
(D) Kinetics of gRNA dimerization in p9 and WT HIV-1
To characterize the kinetics of gRNA dimerization, we incubated 5-
min-old p9, p15 and WT HIV-1 (in the form of ﬁltered supernatants)
for 30 min to 24 h in cell-free medium at 37 °C. We had three goals.
First, estimate how effectively NCp9 can stimulate formation of
igRNAds. Second, estimate whether maturation of gRNA dimers
occurs as quickly in p9 HIV-1 as in WT. Third, estimate the proportion
of igRNAds present inside the cell just before virion release; it is not
technically possible to study 0 min viruses but, in principle, this
information could be obtained by extrapolating the kinetic data to
time 0 min (the level of gRNA dimerization in a 0-min-old HIV-1).
After incubating the ﬁltered supernatants for various speciﬁc
times, we puriﬁed the viral RNAs and measured the electrophoretic
migration and relative intensity of the dimer band. In p9 HIV-1, gRNA
dimerization increased linearly at a rate of approximately 6% per hour
(initial rate of approximately 9% per h) up to the age of 12 h, at which
point p9 gRNAs were almost as dimeric as WT and at least as dimeric
as gRNAs from 48 h p15 HIV-1 (Fig. 6B). The dimers exhibited low
electrophoretic mobility (≤80% of mature mobility) in ≤4-h-old WT
HIV-1 and ≤7-h-old p9 HIV-1, and a mobility undistinguishable from
mature levels (N92% of mature mobility) in approximately 10-h-old
WT and 12-h-old p9 HIV-1 (Fig. 6C). Thus gRNA dimers looked
immature in ≤4-h-old WT and ≤7-h-old p9 HIV-1, and mature in
10-h-oldWT and 12-hold p9 HIV-1. Two representative gels are shown
in Fig. 7. This maturation differential can be entirely explained by the
later appearance of gRNA dimers (~4 h later on average) in p9 HIV-1
relative toWT (Fig. 6B). Thus NCp9 appears at least as potent asNCp7 in
transforming igRNAds into mature dimers, but ineffective at forming
igRNAds.
Fig. 6. (A) Dimerization level and electrophoretic migration of viral RNA isolated from newly released (5 min old, lanes 1–3) and grown-up (48 h old, lanes 4–8) p9, p15 andWT HIV-1.
Exposure times varied from 45min to 48 h. (B) Densitometric analysis showing the percentage of dimers among gRNAs isolated from p9, p15, and WT HIV-1 of speciﬁc ages.
(C) Electrophoretic migration of the gRNA dimers extracted from virions of panel B. The mobility is expressed as percentage of mature dimer mobility. The X h time-points (B and C)
represent gRNAs isolated from X h old viruses as described in Materials and methods and the legend of Fig. 7.
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indicates (Materials andmethods; Song et al., 2007), extrapolating the
p9 curve of Fig. 6B to time 0 min strongly suggests that 10 to 20% of p9
igRNAds are made intracellularly. It is difﬁcult to extrapolate the WT
curve of Fig. 6B to time 0 min. Sufﬁce it to say that the proportion of
WT igRNAds made intracellularly should be at least as high as in p9
HIV-1 (10% to 20%) and less than 90% (Fig. 6B shows that some WT
dimers are made inside HIV-1 during the ﬁrst two hours following cell
release). This provides glimpses of an answer to the third question (is
WT gRNA packaged as an immature dimer?): some, but not all, of the
WT gRNAs are packaged as igRNAds; however, we do not know
whether the igRNAds formed inside the cell represent 10, 50 or 80% of
the total. In p9 HIV-1, on the other hand, gRNA is packagedmostly, but
probably not completely, as monomers. This packaging of RNA
monomers is inconsistent with data on heterozygote gRNA packaging
in HIV-1 particles devoid of gag-pol, env, vif, vpu and vpr (Chen et al.,
2009). Both works will be reconciled in the Discussion.(E) Mapping of NC residues important for transforming immature gRNA
dimers into mature dimers
Kafaie et al. (2008) studied the effect of 40 nucleocapsid mutations
on various physiological parameters, including gRNA dimerization.
However, in terms of dimerization, they studied only the percentage
of gRNA dimers in 48 h HIV-1, without paying heed to the precise
electrophoretic migration of the dimer band.
Table 3 shows that a majority of NC mutations reduced the
electrophoretic mobility of gRNA dimers, i.e. impaired the transition
from immature to mature dimer. To answer the fourth question
(which elements of NC aremost implicated in dimermaturation?), we
reanalyzed all original autoradiograms of Kafaie et al. (2008, 2009),
and carefully measured relative electrophoretic mobilities of the
gRNA dimer bands from all NC mutants (Tables 3 and 4), in order to
determine if the mutant dimers were mostly igRNAds (low mobility)
or mature dimers (WT mobility). Under conditions where dimer
Fig. 7. Electrophoretic migration and dimerization level of viral RNA isolated fromWT and p9 HIV-1 of speciﬁc ages. Virion-containing (and cell-free) supernatants were harvested at
5-min intervals and incubated at 37 °C for various lengths of time such as 0 min, 30 min, 1 h, 2 h, etc., as indicated. Genomic RNA was extracted from the puriﬁed virions and
electrophoresed as described in Materials and methods.
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reduced gRNA dimer mobility to 80–90% of WT: they are R7 in the
N-terminus, 3AF1, 3EF1, F16A, 2GAF1, H23A, H23C, C28H, C28S, and
NC2-2 in the proximal zinc ﬁnger, S3E and ΔAP in the linker, 2KEF2,
2GAF2, W37F, H44A, H44C, C49H, NC1-1 and ΔF2 in the distal zinc
ﬁnger, all joint mutations, and p15 (Table 3). The reduced gRNA
dimer migration is not related to poor proteolytic processing ofTable 3
Effect of NCmutations on gRNA dimerization yield (formation of immature dimers) and
on the electrophoretic migration of gRNA dimers (transformation of immature dimers
into mature dimers).
% (number) of
NC mutationsa
Effect on gRNA
dimerization yield
Effect on electrophoretic
mobility of gRNA dimers
63 (27/43) Reduction Reductionf
2.5 (1/43)b Reduction Noneg
14 (6/43)c Reduction Inconclusiveh
19 (8/43)d None None
2.5 (1/43)e None Inconclusiveh
a Among the 40 NC mutations studied by Kafaie et al. (2008) and the p9, p15 and
p1p6 mutations studied by Kafaie et al. (2009) (Materials and methods).
b The mutation was LL.
c The mutations were R7E, ΔF1, FVI, Δlinker, W37A, and C36S.
d The mutations were N+, N17K, S3, P31A, L+, K38N, p9 and p1p6.
e The mutation was 2KAF2.
f Dimer mobility was 80 to 92% of wild-type in ≥75% of ≥3 independent
experiments. Mutants C28S, NC1-1, NC2-2 and NC2-1 displayed a mixture of roughly
equal amounts of low mobility and high mobility dimers in most experiments.
g Dimer mobility was N92% (and ≤100%) of wild-type in ≥75% of ≥3 independent
experiments.
h Dimer mobility was 80 to 92% of wild-type in b75% of ≥3 independent
experiments, N92% to 100% of wild-type in b75% of ≥3 independent experiments,
and 80 to 100% of wild-type in 100% of experiments.Pr55gag/Pr160gagpol, because only 3 of these 27mutations reduced
Pr55gag processing by N30%, and none reduced it by N40% (Kafaie et
al., 2008); a N70% reduction is needed to increase the proportion of
igRNAds in WT (Kafaie et al., 2009). Nine mutations (N+, N17K, S3,
P31A, L+, K38N, p9, p1p6 and LL) had no detectable effect on
mobility; among them, only LL (long linker) reduced dimer yield
(Table 3). Seven mutants (R7E, ΔF1, FVI, Δlinker, W37A, C36S and
2KAF2) could not be categorized because the migration of their
gRNA dimers was not reproducibly on one side or the other of the
92% cut-off mark used to separate slow moving dimers from dimers
of WT mobility [see caption of Table 3 for details].
Table 3 reveals three interesting correlations: reduced dimer
migration was associated with reduced dimer yield; no change in
dimer yield with no change in migration; and no change in dimer
mobility was generally associated with no change in dimer yield.
Table 4 shows that reduced gRNA dimer yield was associated with
reduced dimer mobility for ≥80% of mutations. This suggests that
many NC mutations impair both fast formation of igRNAds, and theTable 4
Effect of NC mutations that reduced gRNA dimerization yield (formation of immature
dimers) on the electrophoretic mobility of gRNA dimers (transformation of immature
dimers into mature dimers).
% (number) of
NC mutations
Effect on gRNA
dimerization yield
Effect on electrophoretic
mobility of gRNA dimers
80 (27/34) Reduction Reduction
18 (6/34)a Reduction Inconclusive
3 (1/34)b Reduction None
a The mutations were R7E, ΔF1, FVI, Δlinker, W37A, and C36S.
b The mutation was LL.
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Regarding mutation LL and the six mutations of Table 4 that yielded
inconclusive effects on electrophoretic migration, we suggest that
they would reduce both dimer yield and migration if they were
studied in somewhat younger HIV-1, where mutant NC would have
less time to transform igRNAds into mature dimers.
Overall, the results are consistent with the idea that the N-terminus
(see R7), the proximal zinc ﬁnger, the linker, and the distal zinc ﬁnger
each contribute to the transformation of igRNAds into mature dimers,
the linker playing a non electrostatic role in this process (mutation S3
was innocuous).(F) Immature dimer formation is similarly DIS dependent in PR-in, p15
and WT HIV-1, but not exclusively DIS dependent
Song et al. (2007) had shown that deleting the DIS (ΔDIS, or
deleting GCGCGC262) reduced gRNA dimerization by 58% in newly
released WT HIV-1 produced by 293 T cells. Here we ask if ΔDIS
also reduces gRNA dimerization in PR-in and p15 HIV-1. Table 5
shows that ΔDIS reduced gRNA dimerization (the level of igRNAds)
by 35±2% in PR-in HIV-1, 38±5% in newly released p15 HIV-1, and
22±9.7% in newly releasedWTHIV-1. This suggests that the DIS plays
similar roles in formation of immature dimers in PR-in, p15, and WT
HIV-1, and is consistent with the idea that the dimer linkage
structures within these various immature dimers may be identical.Discussion
Viral RNA dimerization is protein-dependent in protease-inactive HIV-1
Our ﬁrst result is that the accumulation of igRNAds seen in PR-in
HIV-1 (a slow process) is protein-dependent (not spontaneous) and
strongly dependent on the NC sequence of Pr55gag/Pr160gag-pol
(Fig. 2). This represents the ﬁrst demonstration that Pr55gag/
Pr160gag-pol has NC-dependent chaperone (RNA annealing) activ-
ity in vivo. Previous in vivo experiments were inconclusive on this
matter: in PR-in HIV-1, it is not known if mutations within Pr55gag
reduce tRNALys3 annealing; in WT, it is not known if they act at the
level of Pr55gag or its maturation products (Cen et al., 1999; Huang
et al., 1998). [In PR-in HIV-1, Pr160gagpol has a reverse transcrip-
tase dependent tRNALys3 annealing activity; it is not known if this
activity is exerted in WT (Cen et al., 2004).] In vitro, Pr55gag can
stimulate tRNA placement on partial HIV-1 RNA transcripts (Feng et
al., 1999; Roldan et al., 2005) and formation of what is now known
as tight HIV-1 RNA dimers (Feng et al., 1999; Laughrea and Jette,
1996a).Table 5
Effect of ΔDIS on gRNA dimerization in PR-in HIV-1, newly released p15 HIV-1 or newly
released wild-type.
Construct name Control % gRNA dimerizationa
(relative to control)
DIS + SQV HXB2+SQVb 65±4
5-min-old ΔDIS-p15 5-min-old p15 c 62±5
5-min-old ΔDIS 5-min-old HXB2d 78±9.5
a [proportion of gRNA dimers in construct divided by the proportion of gRNA dimers
in the control]×100.
b The percentage of gRNA dimers was 60±3 in HXB2+SQV. This value was set at
100 for comparative purposes.
c The percentage of gRNA dimers was 66±2 in 5-min-old p15 HIV-1. This value was
set at 100 for comparative purposes.
d The percentage of gRNA dimers was 73±3 in 5-min-old HXB2. This value was set at
100 for comparative purposes.The proximal zinc ﬁnger and the linker sequences play key roles in the
formation of igRNAds in PR-in HIV-1
Based on the effect of 19 mutations (Table 2), we found that the
proximal zinc ﬁnger and the linker of NC, but not the distal zinc ﬁnger,
appear highly implicated in forming igRNAds in PR-in HIV-1; we also
found that the basic residues of the N-terminus and the linker are not
implicated (mutations R7 and S3). These ﬁndings differ somewhat
from results on the role of NC in WT (rapid) formation of igRNAds
(Kafaie et al., 2008; Laughrea et al., 2001). We had then shown that
the amino-terminus, the proximal zinc ﬁnger, the linker, and the
distal zinc ﬁnger each contributed roughly equally to HIV-1 gRNA
dimerization, the N-terminal and linker segments playing predomi-
nantly electrostatic and steric roles, respectively. Our present results
suggest that fewer basic NC residues and fewer zinc ﬁngers are
needed for Pr55gag/Pr160gag-pol directed gRNA dimerization
(Table 2) than for fast (NCp7-directed) gRNA dimerization (Kafaie
et al., 2008; Laughrea et al., 2001).
Despite these differences, the determinants of PR-in and WT gRNA
dimerization share numerous qualitative similarities. First, all NC
mutations that reduced dimerization yield in PR-in HIV-1 also reduced
it in WT (e.g. ΔF1, H23A, C28S, 2GAF1, S3E, FVI, Δlinker, 2KEF2, H44A,
2GAF2, FL andHC). Second, all harmlessmutations inWTwereharmless
in PR-in HIV-1 (e.g. N+, S3, K38N, and 2KAF2). However, when a
mutation was harmful in both PR-in andWT HIV-1, it always appeared
more harmful in PR-in HIV-1 than in WT (see ΔF1, H23A, 2GAF1, S3E,
FVI, Δlinker, 2KEF2, H44A, 2GAF2, FL and HC). For example, 11 NC
mutations in PR-in HIV-1, but only 3 inWT, reduced gRNA dimerization
byN35%;ΔF1 and FL (H23A+FVI)were ~3- to 4-foldmore impairing in
PR-in HIV-1 than in WT (Table 2). To properly interpret these
quantitative differences, future WT studies need to focus on the effect
of NC mutations in young HIV-1 (b14 h of age) and correct for (or
minimize) the effect that some NC mutations may have on premature
reverse transcription.
To explain the effect of H44A, 2GAF2 and 2KEF2 in PR-in HIV-1
(Table 2), we propose that theymay directly or indirectly interferewith
the proximal zinc ﬁnger of Pr55gag. In NCp7, H44A distorts the
tetrahedral Zn++ coordination (Bombarda et al., 2002), locally unfolds
adjacent residues andmisorient residues of the hydrophobic cleft of the
distal zinc ﬁnger (Stote et al., 2004). Regarding 2GAF2, GlyX2Gly
immediately precedes the histidine of zincﬁngers inmost lentiviral NCs
and all human cellular nucleic acid-binding proteins (Green and Berg,
1989; Leitner et al., 2005; McGrath et al., 2003); sterically nondemand-
ing glycinesmight be essential for a stable ﬁnger structure that does not
interfere with other elements of NC. There are two simple interpreta-
tions for the observed synergistic effects of mutation H23A and FVI in
PR-inHIV-1: (1) the linker and theproximal zincﬁnger have direct roles
in PR-in gRNAdimerization; (2) alternatively, H23Adirectly impairs the
proximal zinc ﬁnger while FVI allosterically extends its inactivation.
For most NC mutants of Figs. 2–4, there is no compelling reason to
verify that Pr55gag processing was sufﬁciently impaired, because the
mutations strongly reduced the percentage of gRNA dimers (Table 2),
which itself indicates that Pr55gag processing was sufﬁciently
impaired. In mutants that had no or modest effects on gRNA
dimerization in the PR-in context, increased Pr55gag processing
(relative to controls) would not have affected data interpretation
unless the mutant Pr55gag were N15% processed (Kafaie et al., 2009),
which is far above the small degree of processing observed in PR-in
HIV-1 (Fig. 1). Moreover, our previous study showed that half of the
NC mutations investigated in Table 2 impaired Pr55gag processing in
WT (Kafaie et al., 2008): this makes unlikely the possibility that they
would increase Pr55gag processing in the presence of saquinavir (the
other half had no effect on processing in WT). Nonetheless, Pr55gag
processing was assessed in R7 and ΔF2 PR-in virions, and found to be
undistinguishable from control PR-in virions (not shown). Thus the
innocuous effect of R7 and ΔF2 (Table 2) cannot be attributed to a
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tion plus partial restoration of proteolytic processing, resulting in a
null apparent impact on gRNA dimerization.Fast formation of igRNAds is directed by NCp15 and NCp7; NCp9 is active
but slow
Our third result: there is a much lower level of immature dimers in
newly released p9 HIV-1 than in newly released p15 HIV-1 (24% vs.
62%; Fig. 6B) and in newly released WT (24% vs. 73%; Fig. 6B). This
suggests that maturation of NCp15 into NCp9: (1) occurs before
NCp15 had time to substantially transform gRNA monomers into
igRNAds; (2) considerably slows down formation of igRNAds (unless
NCp9 is subsequently processed into NCp7). Our results reveal that at
least 76% of gRNAs are packaged asmonomers when NCp7 production
is blocked (result with p9 HIV-1). It follows that NCp7 must
accumulate inside the cell in order that WT gRNAs shall be
predominantly packaged as immature dimers. Interestingly, consid-
erable amounts of processed capsid proteins (Aldovini and Young,
1990; Clavel and Orenstein, 1990; Gottlinger et al., 1989; Lever et al.,
1989) and processed NC (Pettit et al., 1994; Sheng et al., 1997) are
readily found in extracts of transfected cells; the identiﬁcation of
CAp24 in cell extracts (Aldovini and Young, 1990; Clavel and
Orenstein, 1990; Gottlinger et al., 1989; Lever et al., 1989) implies
the presence of an equal amount of NCp15 and other processed NC,
because the earliest proteolytic cleavage in Pr55gag breaks it into
NCp15 and a capsid-containing polypeptide (Pettit et al., 2002).
Viral RNA dimers accumulate at similar rates in p9 HIV-1 (Fig. 6B)
and in PR-in HIV-1 (Song et al., 2007). This suggests that NCp9 is more
similar to Pr55gag/Pr160gag-pol than to NCp15, in ability to form
igRNAds. PR-in and p9 HIV-1 are therefore useful tools to slow down
the rate of formation of igRNAds and provide easier experimental
access to this early step of gRNA dimerization.
Mutation p9 abolishes viral replication (Kafaie et al., 2009). This
suggests that NCp7 has important physiological roles that NCp9
cannot exert. Fig. 6B shows one function that is much better exerted
by NCp7 than by NCp9: produce a maximal level of immature gRNA
dimers in newly released HIV-1.
Using virus-like particles devoid of gag-pol, env, vif, vpu and vpr
proteins, Chen et al. (2009) obtained data indirectly suggesting that
HIV-1 gRNAs are predominantly packaged in some dimeric form
despite the absence of NCp15, NCp9 and NCp7. Assuming their
constructs mimic the assembly of PR-in HIV-1, their results can be
reconciled with ours by postulating that igRNAds are preceded by
preimmature dimers. This idea explains or accounts for the packaging
of dimers in PR-in virus-like particles (Chen et al., 2009), the one-step
recruitment of gRNA in imagings of the assembly of individual PR-in
HIV-1 (Jouvenet et al., 2009), the absence of igRNAds in newly
released PR-in HIV-1 (Song et al., 2007), and a normal complement of
immature dimers in grown-up PR-in HIV-1 bearing mutations that
seriously reduce packaging (such as N+ and ΔF2). It does not exclude
the possibility of subsequent dimerization events prior to gRNA
packaging or virus release, such as a shade of immature dimer
formation in p9 HIV-1 and considerable formation of immature
dimers in p15 and WT HIV-1. [Caveat: if the constructs of Chen et al.
(2009) assembled slower than PR-in HIV-1, their dimers may be
igRNAds. Their gRNAs may also have dimerized differently from
genuine gRNAs, because short HIV-1 RNAs generally dimerize more
easily than long ones (Laughrea and Jette, 1996a) and gRNA dimers
from analogous virus-like particles are more stable thanWT (Sakuragi
and Panganiban, 1997).]
We propose that gRNA is packaged as preimmature dimers in
PR-in HIV-1, predominantly preimmature dimers in p9 HIV-1, and
a mixture of preimmature and immature dimers in p15 and WT
HIV-1.The transformation of igRNAds into mature dimers is exclusively directed
by NCp9 and NCp7
Our fourth result is that NCp15 cannot transform igRNAds into
mature dimers, while NCp9 appears as effective as WT in this process
(Fig. 6A and C). In the in vitro literature, one can ﬁnd evidence that
NCp9 is more efﬁcient than NCp15 at binding and aggregating single
and double-stranded nucleic acids (Mirambeau et al., 2006), but less
efﬁcient than NCp15 and NCp7 at rapidly binding and dissociating
from nucleic acids (Cruceanu et al., 2006). Processivity of reverse
transcription is reduced ~40% in the absence of NCp7 and NCp9
(Coren et al., 2007). Perhaps reverse transcription is impaired when
gRNA dimers are immature.
Since NCp9 canmature igRNAds, one may wonder if NCp7 is active
in this process. It is active, based on two observations: (1) 48 h p1p6
HIV-1 produce no NCp9 (Kafaie et al., 2009) yet contain only mature
gRNA dimers (Table 3); (2) maturation of WT igRNAds occurs when
virions are N4 h old (Fig. 6C), at which age there are no detectable
NCp15 and NCp9 in them (data not shown). Thus, one can safely
consider that NCp7 can mature igRNAds, and that, in WT, most if not
all gRNA dimers are matured by NCp7.
Mapping of NC residues important for maturation of igRNAds
As ﬁfth result, we have found 27 NC mutations that reduced the
electrophoretic migration of gRNA dimers from 48 h HIV-1 (Tables 3
and 4) even though they did not impair Pr55gag processing, or did not
impair it sufﬁciently to inﬂuence dimer migration (Kafaie et al., 2008,
2009). This is the ﬁrst demonstration that NC mutations impair the
transition from immature to mature gRNA dimers in lentiviruses.
Since 48 h p15 HIV-1 contain no mature gRNA dimers (Fig. 6A and C),
these NC mutations impair maturation of gRNA dimers by acting at
the level of NCp9 and/or NCp7. They conﬁrm thatmere disappearance
of Pr55gag/Pr160gag-pol does not allow maturation of igRNAds (see
p15 HIV-1), and they give insights into the residues and segments of
NCp7 that direct gRNA dimer maturation. These 27 mutations have
probably similar effects within NCp9, but we would need to study
them within p9 HIV-1 to address this issue.
Our ﬁnding supports numerous in vitro data indicating that NCp7
can stabilize already formed dimers of partial HIV-1 transcripts (Baba
et al., 2003; Mujeeb et al., 2007; Muriaux et al., 1996b; Remy et al.,
1998; Takahashi et al., 2000, 2001), and that mutations in the zinc
ﬁngers of NCp7 can reduce formation of extended duplex dimers
(Baba et al., 2003; Takahashi et al., 2001), also called tight dimers
(Laughrea and Jette, 1996a). However, since NC7 and NCp9 directly
stimulate formation of both immature and mature gRNA dimers
(Fig. 6), it is not clear if extended duplexes (or stabilized dimers) are
proper models for igRNAds or for mature gRNA dimers. We speculate
that tight dimers are fair models for igRNAds while kissing dimers
(Laughrea and Jette, 1996a; Muriaux et al., 1996a; Paillart et al., 1996)
might be seen as models for preimmature gRNA dimers.
The effect of NC mutations on gRNA dimerization is very unlikely
to be exerted in cis because, though there may be gRNA dimerization
sites downstream of the 5’ untranslated region (Song et al., 2008),
they do not include the NC region of gRNA (Sakuragi et al., 2002). In
other retroviruses, a mutation in the NC sequence of Moloney Murine
Leukemia Virus reduced Kirsten Sarcomas Virus gRNA dimermobility;
this indicated that the mutation acted in trans (Fu and Rein, 1993).
ΔDIS plays similar roles in PR-in, p15 and WT HIV-1
In terms of forming igRNAds, the DIS plays a similar role in PR-in,
p15 andWT HIV-1 (Table 5). However, this does not clarify whether it
forms a kissing complex (Laughrea and Jette, 1996a; Muriaux et al.,
1996a; Paillart et al., 1996) or an extended duplex (Laughrea and
Jette, 1996a; Muriaux et al., 1996a; Paillart et al., 1996) in these
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have switched from intra-strand to inter-strand base-pairing; this
increases the number of inter-strand base pairs to 28.) Immature and
mature gRNA dimers differ by only 9 °C in dissociation temperature
(Buxton et al., 2005; Fu et al., 1994, 2006; Shehu-Xhilaga et al., 2001,
2002; Song et al., 2007) while kissing dimers and extended duplexes,
prepared in vitro from partial RNA transcripts, differ by 20 °C
(Laughrea and Jette, 1996b; Muriaux et al., 1996a). It is possible
that the DIS exists as an extended duplex in immature gRNA dimers.
The 6 intermolecular base pairs of a kissing dimer may not sufﬁce to
retain together 18 000 ribonucleotide residues (the number of
residues in 2 gRNAs) during virus extraction and electrophoretic
procedures.
Other dimerization sites contribute to the residual igRNAds
present in the ΔDIS mutants of Table 5. The 5’ TAR stem-loop is a
plausible candidate. Song et al. (2008) found that ΔTAR (deletion of
other 5' TAR stem-loop) impaired dimerization more than ΔDIS in
virions produced by Cos-7 and HeLa cells.
Materials and methods
Plasmid constructions
Proviral vector pSVC21.BH10 encodes a HIV-1HXB2 clone. Mutant
proviral vectors, except for p15, were described previously (Kafaie
et al., 2008, 2009). The p15 plasmid was constructed from the
p9 mutant (Kafaie et al., 2009) by PCR mutagenesis, using primer
5'-cctacaagggaaggccagggaattctcttcagagcagaccagagccaacag-3': a
PCR-produced DNA fragment extending from ApaI to BclI restric-
tion sites was synthesized and ligated into pSVC21.BH10 vector.
The mutated DNA fragment was sequenced (ACGT Inc., Toronto) to
verify that the desired mutation, and no other mutation, was
introduced by the mutagenic procedure.
Cell culture and virus-containing cell supernatants
HeLa cells were cultured at 37 °C in a culture medium consisting of
Dulbecco's modiﬁed Eagle's medium (DMEM), 10% fetal calf serum,
ampicillin and streptomycin (Invitrogen). The polyfect transfection
reagent (Qiagen) was used to transfect 18 μg of proviral DNA into 40%
to 80% conﬂuent HeLa cells in 150×25 mm Petri dishes containing
25 ml of culture medium. Unless otherwise speciﬁed, supernatants
were harvested 48 h after transfection and ﬁltered through a 0.2 μm
pore size ﬁlter with a 20 ml syringe, to remove cells. Such super-
natants were the standard, or default, source of viruses. When these
viruses need to be distinguished from newly released viruses or
viruses of speciﬁc ages, they are termed 48 h or grown-up HIV-1.
To prepare supernatants containing PR-in HIV-1, 0.6 μM of
saquinavir (Hoffmann-La Roche) was added shortly after transfection.
To prepare supernatants containing PR− virions, the aspartic acid at
position 25 of the viral protease active site was replaced by arginine
(Song et al., 2007).
Supernatants containing newly released viruses or viruses of speciﬁc
ages
On day 1, cells were seeded into Petri dishes (20 ml of culture
medium/dish), and incubated at 37 °C. On day 2, transfection was
done. 24 to 30 h after transfection, the virus-containing supernatant
was discarded and cells were washed with 10 ml of 37 °C phosphate-
buffered saline (PBS) per dish. Immediately after, 5 ml of fresh heated
culture mediumwas added and each Petri dish was incubated at 37 °C
for 5 min. Supernatants were then collected, passed through a 0.2-μm
pore size ﬁlter (to remove cells) and stored at−80 °C. After collecting
and ﬁltering 5 min supernatants from four Petri dishes, the dishes
were reused (rinsed with 10 ml of heated PBS, replenished with 5 mlof fresh heated culture medium and further incubated for 5 min) to
collect a second batch of 5 min supernatants. This allowed collecting
multiple repeats of 5 min samples for a given experiment. Typically,
four Petri dishes of transfected conﬂuent cells were used to collect
viruses for a given experiment. Each result shown here is the average
from at least 3 independent transfections. Given the time required for
replacing medium, harvesting supernatants and ﬁltering (during
which new viruses were released and viruses already 5 min old at
harvest-time continued aging), as well as for cooling the ﬁltrate at
−80 °C, we estimate that 5 min viruses actually represent viruses
ranging in age from 5 min to 15 min old.
For preparation of viruses that were x h of age, virus-containing
supernatants were harvested at 5-min intervals, ﬁltered, and incubated
at 37 °C for 30 min, 1, 2, 3.5, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18 or 24 h, as
indicated.
Virus puriﬁcation and isolation of HIV-1 viral RNA
Filtered supernatants were centrifuged at 35,000 rpm (SW41 rotor,
4 °C, 1 h) through a 2 ml 20% (w/v) sucrose cushion in phosphate-
buffered saline (PBS). The virus pellet was dissolved in 400 μl of sterile
lysis buffer [50 mM Tris (pH7.4), 50 mM NaCl, 10 mM EDTA, 1% (w/v)
SDS, 50 μg tRNA per ml, and 100 μg proteinase K per ml], and extracted
twice at 4 °C with an equal volume of buffer-saturated phenol/
chloroform/isoamyl alcohol (25:24:1) (Invitrogen). The aqueous
phase was precipitated overnight at −80 °C with 0.1 volume of 3 M
sodium acetate (pH 5.2) and 2.5 volumes of absolute ethanol, and
centrifuged at 14,000 rpm in anEppendorf 5145micro centrifuge at 4 °C
for 30 min. The gRNA pellet was rinsed with 70% (v/v) ethanol, and
dissolved in 10 μl of buffer S [10 mMTris (pH7.5), 100 mMNaCl, 10 mM
EDTA and 1% SDS] (Song et al., 2007).
Electrophoretic analysis of HIV-1 gRNA
Non-denaturingNorthern (RNA) blot analysiswas used to assess the
dimerization of viral gRNA (Song et al., 2007). Electrophoretic
conditions were 4 V/cm at 4 °C for 4 h in 1% (w/v) agarose (Bioshop
Canada) gel in TBE2 (89 mMTris-borate, 2 mMEDTA, pH8.3), or 4 V/cm
at 4 °C for 5 h in 1.2% (w/v) agarose, depending on the experiments. For
all kinetic studies of gRNAdimerization andelectrophoreticmigration of
the dimer band (Figs. 6 and 7), 1.2% agarosewas used, as it increases the
separation between immature and mature gRNA dimers. After
electrophoresis, the gel was heated at 65 °C for 30 min in 10% (v/v)
formaldehyde, and the embedded RNAs were diffusion transferred to a
Hybond N+ nylon membrane (Amersham). After drying at room
temperature for 2 h, cross linking (3000 J in a UV Stratalinker), and
prehybridization at 42 °C for 2 h in 6× SSPE [1× SSPE is 0.15 M NaCl,
10 mM NaH2PO4, and 1 mM EDTA (pH 7.4)], 50% (v/v) deionized
formamide, 10% dextran sulfate, 1.5% SDS, 5× Denhardt's reagent,
100 μg/ml salmon spermDNA, themembranewashybridizedovernight
in prehybridization buffer devoid of Denhardt's reagent in a rotating
hybridization oven at 42 °C to approximately 25 μCi of 35S-labeled
antisense RNA 636-296 (a 356-nt RNA that is the antisense of the 296 to
636 region of the HIV-1 genome prepared with the SP6 Megascript
kit [Ambion]) (Laughrea and Jette, 1996a). This was followed by two
30-min washes in 1× SSC [1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate]–0.1% SDS at room temperature and 37 °C, and one
30-min wash in 0.2× SSC–0.1% SDS at 45 °C (Laughrea et al., 1997),
and exposure to a Kodak BioMax MR X-ray ﬁlm.
Densitometric analysis
The autoradiograms were scanned and analyzed using the NIH
1.6.3 program. Care was taken to scan variously exposed ﬁlms to
guard against over-exposed or under-exposed bands. To evaluate the
proportion of dimers, the monomer and dimer bands were typically
235M. Jalalirad, M. Laughrea / Virology 407 (2010) 225–236considered of equal width. Material located elsewhere in the gels (e.g.
extraneous or very slow migrating material in some lanes) was not
taken into account in the calculation of the percentage of dimers. All
results regarding gRNA dimer migration or the percentage of gRNA
dimers are reported as average ± standard error. When there was no
evidence of a dimer peak but only a faint lowmobility shoulder (e.g. in
mutants S3E, FL, HC andΔF1), the entire shoulder (wider than a dimer
band) was considered as dimeric material, in order to be sure that we
do not overestimate the impact of the mutations.
Effect of NC mutations on the electrophoretic migration of the gRNA
dimer band
All autoradiograms of Kafaie et al. (2008, 2009) were examined for
evidence of change in electrophoreticmigration of the dimer band as a
function of mutations in the nucleocapsid protein. In these auto-
radiograms, gRNA dimers from most NC mutants had a mobility that
was 85–90% of wild-type mobility, i.e. intermediate between the
mobility of PR− gRNA dimers (80–85% of wild-type) and the mobility
of wild-type gRNA dimers (not shown). An NCmutationwas scored as
reducing dimer mobility if dimer migration was 80% to 92% of wild-
type mobility in ≥75% of ≥3 independent experiments. If a mutation
did not reduce dimer migration or reduced it to N92% of wild-type in
≥75% of ≥3 independent experiments, it was scored as ineffective.
Otherwise, results were judged inconclusive.
Western blotting
8 ml of ﬁltered virus-containing supernatant was pelleted through
a 2-ml 20% sucrose cushion by ultracentrifugation. The virus pellet
was dissolved in lysis buffer (without proteinase K, SDS or tRNA),
heated at 95 °C, and fractionated by electrophoresis on SDS/12%
polyacrylamide gels. Rabbit anti-capsid antibody (ABT-Trinity Bio-
technology, CA, USA) and rabbit NCp7 antiserum (kind gift from R. J.
Gorelick) were used to probe the membranes. Horseradish peroxi-
dase-conjugated anti rabbit antibody (Amersham) was used as the
secondary antibody and proteins were detected by enhanced
chemiluminescence (Amersham). The signals for CAp24-containing
proteins were quantitated by densitometric scanning and analyzed
with the NIH 1.6.3 program. The signal obtained from the CAp24 plus
the p41 bandswas divided by the total signal obtained from all capsid-
containing proteins to calculate Pr55gag processing level.
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